Clinical Nutrition Market Latest Trends, Industry Size and Competitive Landscape

BySanket Badgujar
Market Research-d0d2e235

The Clinical Nutrition Market is expected to grow at an 8.1% CAGR by 2032 over the forecast period, reaching a valuation of US$ 19,727.4 Mn by 2028, up from US$ 11,734 Mn in 2021.

The pivotal trends in the Clinical Nutrition Market include a growth in cancer research and development efforts, as well as an increase in pre-mature birth rates.

Request a report sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14395?utm_source=4018419&utm_medium=Sanket

The COVID-19 pandemic is likely to have a significant impact on the clinical nutrition market, as the demand for nutritional control, particularly among youngsters and the elderly, continues to rise. The demand for clinical nutrition products is increasing as a result of the ongoing COVID-19 crisis, as customers seek various immunity-boosting options to avoid becoming infected with the new coronavirus.

Attributes

Details

Clinical Nutrition Market CAGR (2022 – 2032)

8.1%

 

Clinical Nutrition Market (2021)

US$ 11,734 Mn

Clinical Nutrition Market (2028)

US$ 19,727.4 Mn

With the outbreak of the pandemic, older individuals and patients are at danger of starvation. The illness also causes a loss of appetite, as well as other symptoms like anosmia dysgeusia or diarrhoea, which both increase the risk of disease-related malnutrition. COVID-19-induced acute starvation resulted in increased muscle mass and nutrients loss and a weakening of immunological responses.

The rise in the incidence of metabolic diseases, high healthcare spending, and the expansion of the middle class in emerging nations are driving the clinical nutrition market’s growth. Furthermore, the expanding older population and the development of therapeutic nutrition products tailored to the needs of the elderly are likely to fuel clinical nutrition market expansion. However, several constraints, such as a lack of awareness for clinical medical nutrition and tight regulations, are impeding clinical nutrition market expansion.

The oral segment, by route of administration is anticipated to have the largest clinical nutrition market share and is expected to maintain its dominance during the forecast period, owing to an increase in malnourished patients with malignancy, chronic disease, and/or anorexia, as well as an increase in the incidences of chronic diseases such as cancer, gastrointestinal disorders, and metabolic disorders, which provide lucrative clinical nutrition market growth opportunities for the oral clinical nutrition market.

On the basis of application, the cancer segment is likely to drive the clinical nutrition market throughout the forecast period, due to a growth in the number of individuals suffering from chronic ailments such as cancer and diabetes, as well as a growing elderly population base.

The rising prevalence of chronic illnesses has prompted an increase in clinical nutrition prescriptions, since patients suffering from such ailments are deficient in a number of critical nutrients. Furthermore, the growing obesity population as a result of poor food habits and physical inactivity will drive clinical nutrition market growth.

North America accounted for the greatest clinical nutrition market share and is expected to retain its dominance because to high R&D spending, the presence of key businesses and their product availability, and the region’s well-established healthcare infrastructure.

Asia-Pacific is predicted to have the greatest CAGR in the clinical nutrition market throughout the projection period, as Asian governments spend in the development of healthcare infrastructure.

Key Takeaways:

  • The enteral segment is estimated to be the fastest growing segment of clinical nutrition market at a CAGR of 7.30% during the forecast period.
  • The cancer segment is expected to register highest CAGR of 10.50% in clinical nutrition market during the forecast period.
  • Due to the increased awareness of the importance of clinical nutrition in cancer therapy, the cancer category surpassed USD 7.1 billion.
  • The United States dominated the North American clinical nutrition market in 2020, with a market value of about USD 11.2 billion.
  • Germany now holds a dominant clinical nutrition market share of the European clinical nutrition market, which is expected to reach USD 3.8 billion by 2027.
  • Due to the rising number of preterm deliveries, the infant feeding sector commanded more than 54.7 % of the clinical nutrition market share.
  • Due to the high frequency of malnutrition and associated diseases, the paediatric segment of the clinical nutrition market accounted for 58.7% of revenue share in 2020.
  • By 2027, the clinical nutrition market’s internet channel sector is expected to reach USD 13 billion.

Competitive Landscape:

  • Nestle Health Science (part of Nestle SA) signed a formal agreement to buy IM HealthScience in August 2020. IM HealthScience provides medical nutrition solutions that address particular dietary requirements for a variety of disorders. The firm was able to enhance and expand its dietary management product offering as a result of this strategic purchase.
  • Danone announced a EUR 100 million investment in the growth of its specialist nutrition products in China in July 2020. This investment helped the firm expand its nutritional product offerings to meet the demands of Chinese consumers and reclaim its clinical nutrition market share in the nation.

Key Players:

Nestle Health Science, Fresenius Kabi, Abbott Laboratories, Danone, B Braun Melsungen AG, Baxter International Inc., Mead Johnson (Reckitt Benckiser), and Perrigo are some of the key players in clinical nutrition market.

Key Segments:

By Consumer:

  • Pediatric
  • Adult

By Product:

  • Infant Nutrition
  • Parenteral Nutrition

By Application:

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Others

By Distribution Channel:

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channes
  • Others

0